For the Inventor, By the Inventor

Enter assignee name

Zambon S.p.a.

USPTO Granted Patents = 78

CIPO Patents = 3

EPO Patents = 21

Trademarks = 19

Forward Citations = 480

Loading Chart...

Loading Chart...

84 inventors (with patents filed for the assignee):

Claudio Giordano (27 out of 59 patents)

Graziano Castaldi (23 out of 69 patents)

Dario Chiarino (21 out of 33 patents)

4. Davide Della Bella (18 out of 22 patents)

5. Angelo Carenzi (14 out of 24 patents)

6. Silvia Cavicchioli (10 out of 14 patents)

7. Fulvio Uggeri (9 out of 58 patents)

8. Giancarlo Jommi (7 out of 7 patents)

9. Alberto Moretto (4 out of 4 patents)

10. Giovanni Caponetti (4 out of 26 patents)

11. Loretta Maggi (4 out of 6 patents)

12. Mauro Napoletano (4 out of 30 patents)

13. Franco Pellacini (4 out of 31 patents)

14. Roberto Pagliarin (4 out of 4 patents)

15. Mariano Meneghin (4 out of 7 patents)

Core Competencies:

Non-Cystic Fibrosis Bronchiectasis

N-Acetylcysteine

Safinamide

Pharmaceutical Compositions

Aerosol Apparatus

Dermatological Preparations

Optically Active Compounds

Antibiotic Activity

Gabapentin

Ischemia Treatment

Thiazolidine Derivatives

Vaginal Dryness Treatment

78 patents: Sort by Forward Citations

1. 12178841 - Treatment of non-cystic fibrosis bronchiectasis (2024-12-31),

2. 12102660 - Association of N-acetylcysteine and colistin for use in bacterial infections (2024-10-01),

3. 11918552 - N-acetylcysteine for use as antibacterial agent (2024-03-05),

4. 11707441 - Safinamide for treating myotonia (2023-07-25),

5. 11382948 - Association of N-acetylcysteine and colistin for use in bacterial infections (2022-07-12),

6. 11103457 - Pharmaceutical compositions comprising safinamide (2021-08-31),

7. 10792257 - Pharmaceutical compositions comprising safinamide (2020-10-06),

8. 10583082 - Composition comprising at least two dry powders obtained by spray drying to increase the stability of the formulation (2020-03-10),

9. 10517828 - Composition comprising at least one dry powder obtained by spray drying to increase the stability of the formulation (2019-12-31),

10. 10449147 - Pharmaceutical composition containing budesonide and formoterol (2019-10-22),

11. 10226421 - Pharmaceutical composition containing budesonide and formoterol (2019-03-12),

12. 9808427 - Swallowable N-acetylcysteine tablets (2017-11-07),

13. 9248151 - Multipurpose gel for vaginal dryness with direct and delayed effect (2016-02-02),

14. 8927017 - Pharmaceutical preparation containing gabapentin (2015-01-06),

15. 8522774 - Aerosol apparatus, in particular for children (2013-09-03),

Zambon S.P.A. is a leading Italian pharmaceutical company specializing in the development and commercialization of innovative medicines for respiratory, pain management, central nervous system, and rare diseases. With over 100 years of experience, Zambon is dedicated to improving the health and well-being of patients worldwide. Their commitment to research, scientific excellence, and collaborative partnerships has enabled them to create breakthrough treatments and bring them to market. Zambon aims to make a positive impact on patients' lives by providing high-quality, safe, and effective healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

78 Patents

#1 in Bresso

#105 in Italy

#9,298 in the World

Zambon S.p.a.

Forward Citations = 480

84 inventors:

Claudio Giordano (27 out of 59 patents)

Graziano Castaldi (23 out of 69 patents)

Dario Chiarino (21 out of 33 patents)

4. Davide Della Bella (18 out of 22 patents)

5. Angelo Carenzi (14 out of 24 patents)

Please report any incorrect information to support@idiyas.com

Loading…